Continuous subcutaneous insulin infusion leads to immediate, stable and long-term changes in metabolic control.

about

Therapeutics of diabetes mellitus: focus on insulin analogues and insulin pumps.

P2860

Q33879565-BA00AA03-CDAD-4DDD-85AE-52C6D53D4A7D

P2860

Continuous subcutaneous insulin infusion leads to immediate, stable and long-term changes in metabolic control.

Item

http://www.wikidata.org/entity/Q46707960

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Continuous subcutaneous insuli ...... changes in metabolic control.

@en

Continuous subcutaneous insuli ...... changes in metabolic control.

@nl

type

Item

label

Continuous subcutaneous insuli ...... changes in metabolic control.

@en

Continuous subcutaneous insuli ...... changes in metabolic control.

@nl

prefLabel

Continuous subcutaneous insuli ...... changes in metabolic control.

@en

Continuous subcutaneous insuli ...... changes in metabolic control.

@nl

P1476

Continuous subcutaneous insuli ...... changes in metabolic control.

@en

P2093

A Kliegel

http://www.w3.org/2001/XMLSchema#string

B Bach-Kliegel

http://www.w3.org/2001/XMLSchema#string

C Fischer

http://www.w3.org/2001/XMLSchema#string

D Zimprich

http://www.w3.org/2001/XMLSchema#string

I Aberle

http://www.w3.org/2001/XMLSchema#string

K Langer

http://www.w3.org/2001/XMLSchema#string

M Gorny

http://www.w3.org/2001/XMLSchema#string

M Kliegel

http://www.w3.org/2001/XMLSchema#string

P2860

Continuous subcutaneous insulin infusion (CSII) in the Veneto region: efficacy, acceptability and quality of life.

Insulin pump therapy in type 1 pediatric patients: now and into the year 2000.

Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials

Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes.

Insulin pump therapy: a meta-analysis.

Handling drop-out in longitudinal studies.

Beneficial effects of continuous subcutaneous insulin infusion in older patients with long-standing type 1 diabetes.

The relation of glycaemia to the risk of development and progression of retinopathy in the Diabetic Control and Complications Trial.

Post-prandial glucose excursions following four methods of bolus insulin administration in subjects with type 1 diabetes.

Continuous subcutaneous insulin infusion in children and adolescents with diabetes mellitus: decreased HbA1c with low risk of hypoglycemia.

P304

329-335

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1463-1326.2007.00707.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2008-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5518152

http://www.w3.org/2001/XMLSchema#string

P698

18333891

http://www.w3.org/2001/XMLSchema#string

Continuous subcutaneous insulin infusion leads to immediate, stable and long-term changes in metabolic control.

about

P2860

P2860

Continuous subcutaneous insulin infusion leads to immediate, stable and long-term changes in metabolic control.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698